# Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke

> **NCT04918719** · PHASE2 · COMPLETED · sponsor: **Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center** · enrollment: 4 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Acetylcysteine
- **DRUG:** Dextrose in Water

## Key facts

- **NCT ID:** NCT04918719
- **Lead sponsor:** Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-02
- **Primary completion:** 2024-09-17
- **Final completion:** 2024-09-17
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918719, "Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04918719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*